两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001104659-19-045963 Size: 7 MB 网页链接
$Onconova医疗(ONTX)$ 8-K - Current report Filed: 2019-08-14 AccNo: 0001104659-19-045789 Size: 174 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova医疗(ONTX)$ 美东时间 2019-08-14 盘前 披露财报,预期EPS -0.98 网页链接
$Onconova医疗(ONTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001104659-19-042316 Size: 27 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Onconova医疗(ONTX)$ 内部交易: 2019-07-10,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,2742普通股, $2.81
$Onconova医疗(ONTX)$ 内部交易: 2019-07-09,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,8185普通股, $2.84
$Onconova医疗(ONTX)$ 内部交易: 2019-06-27,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,1458普通股, $3.45
$Onconova医疗(ONTX)$ 内部交易: 2019-06-25,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,1380普通股, $3.40
$Onconova医疗(ONTX)$ 8-K - Current report Filed: 2019-06-19 AccNo: 0001104659-19-036364 Size: 64 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Onconova医疗(ONTX)$ D - Notice of Exempt Offering of Securities Filed: 2019-06-04 AccNo: 0001104659-19-033519 Size: 14 KB 网页链接